Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.

Sakaki K, Murakami T, Yoshida H, Otani D, Miyake KK, Shimizu Y, Fujimoto H, Yabe D, Nakamoto Y, Inagaki N

Open source

DOI
10.2337/db25-1127
Published
2026 May 1
Container
Diabetes
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/db25-1127,
  title = {Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.},
  author = {Sakaki K and Murakami T and Yoshida H and Otani D and Miyake KK and Shimizu Y and Fujimoto H and Yabe D and Nakamoto Y and Inagaki N},
  year = {2026},
  journal = {Diabetes},
  doi = {10.2337/db25-1127},
  url = {https://doi.org/10.2337/db25-1127}
}

RIS

TY  - JOUR
TI  - Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
AU  - Sakaki K
AU  - Murakami T
AU  - Yoshida H
AU  - Otani D
AU  - Miyake KK
AU  - Shimizu Y
AU  - Fujimoto H
AU  - Yabe D
AU  - Nakamoto Y
AU  - Inagaki N
PY  - 2026
JO  - Diabetes
DO  - 10.2337/db25-1127
UR  - https://doi.org/10.2337/db25-1127
ER  - 

APA

K, S., T, M., H, Y., D, O., KK, M., Y, S., H, F., D, Y., Y, N., & N, I. (2026). Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.. Diabetes. https://doi.org/10.2337/db25-1127

Source records